In this study, CY-09 was used to inhibit the activation of NLRP3 inflammasome, leading to the restoration of glucose metabolism, as demonstrated by the increases in the expression and distribution of glucose transporters and related enzymes and the attenuation of insulin resistance. This evidence concerns the gene NLRP3 and Insulin resistance.